We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Jury Hands Innogenetics $7M In Damages

Law360 (September 11, 2006, 12:00 AM EDT) -- A week after returning a verdict in Innogenetics’ favor, a federal jury has awarded the Belgian biotechnology company $7 million in damages in its longstanding battle with Abbott Laboratories over a hepatitis C virus genotyping patent.

Innogenetics announced the damages award on Friday, revealing that the amount could be trebled due to the willful infringement finding against Abbott.

"This is a landmark victory for Innogenetics, and possibly for other innovators like us out there," said Innogenetics Chief Executive Frank Morich.

The Belgian biotechnology company also confirmed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.